Trial intelligence / Profile preview

Tiotropium in Preterm-Born Children With Bronchial Obstruction

NCT07827859Phase 4Not yet recruiting

Sponsor
General University Hospital in Prague
Start
Nov 2026
Primary completion
May 2029
Countries
1
01

Overview

Phase 4, randomised, open-label trial of tiotropium in bronchial obstruction (2 arms), sponsored by General University Hospital in Prague. Primary endpoint: Absolute change from Baseline in Forced Expiratory Volume in 1 Second at 28 weeks. Planned start Nov 2026; status: not yet recruiting.

02

Drugs

tiotropium
03

Conditions

bronchial obstruction

Beyond the preview

Go deeper on NCT07827859.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT07827859.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call